live
hiv
subsaharan
africa
recent
estim
indic
peopl
may
die
annual
cryptococc
mening
region
although
complet
diagnost
autopsi
cda
consid
gold
standard
determin
caus
death
seldom
perform
low
incom
set
studi
cda
perform
deceas
patient
mozambiqu
n
brazil
n
depth
histopatholog
microbiolog
analys
carri
case
die
cryptococcosi
determin
cryptococc
speci
molecular
serom
type
antifung
suscept
also
describ
organ
affect
review
clinic
present
patient
manag
among
case
includ
fatal
cryptococc
infect
diagnos
cryptococcu
respons
death
among
hivposit
patient
ci
includ
four
matern
death
one
third
case
correspond
c
gattii
vgi
vgiv
molecular
type
strain
remain
infect
type
caus
c
neoforman
var
grubii
vni
strain
level
premortem
clinic
suspicion
low
patient
die
within
first
hour
admiss
cryptococcosi
respons
signific
proport
aidsrel
mortal
clinic
diagnosi
patient
manag
inadequ
support
need
cryptococc
screen
earli
detect
diseas
first
report
presenc
c
gattii
infect
mozambiqu
cryptococcosi
lead
caus
mening
adult
live
hiv
subsaharan
africa
number
cryptococc
mening
cm
case
region
estim
rang
novemb
march
complet
diagnost
autopsi
cda
perform
deceas
patient
two
studi
site
two
hundr
twentythre
case
recruit
mozambiqu
adult
year
age
women
matern
death
e
women
die
pregnanc
partum
postpartum
within
day
termin
pregnanc
children
month
year
age
male
femal
sixtyon
case
recruit
brazil
adult
male
femal
includ
one
matern
death
two
children
descript
studi
design
inclus
criteria
case
publish
elsewher
case
fulfil
inclus
criteria
includ
studi
cda
request
clinician
part
medic
evalu
patient
verbal
inform
consent
perform
autopsi
given
rel
traumat
death
exclud
member
studi
staff
task
liais
famili
case
death
occur
pediatr
depart
clinician
ask
consent
postmortem
examin
clinic
record
avail
regard
admiss
preced
death
patient
review
clinic
data
collect
standard
manner
autopsi
procedur
determin
caus
death
autopsi
procedur
descript
patholog
microbiolog
method
use
report
elsewher
briefli
sampl
blood
cerebrospin
fluid
csf
bone
marrow
key
organ
liver
lung
cn
spleen
kidney
well
uteru
women
reproduct
age
collect
histopatholog
microbiolog
analysi
microbiolog
method
includ
univers
screen
relev
pathogen
eg
hiv
viral
hepat
tuberculosi
malaria
bacterialfung
cultur
autopsi
sampl
target
screen
depend
patient
condit
ie
screen
cryptococcu
toxoplasma
gondii
pneumocysti
jirovecii
hivinfect
case
addit
specif
test
accord
histopatholog
find
follow
analysi
cda
sampl
panel
compos
pathologist
microbiologist
clinician
expertis
infecti
diseas
epidemiolog
evalu
data
includ
clinic
inform
assign
final
caus
death
laboratori
method
case
caus
death
assign
cryptococc
infect
character
histolog
evalu
includ
period
acidschiff
stain
pa
sampl
lung
cn
bone
marrow
spleen
liver
kidney
uteru
well
grocottgomorimethenamin
silver
stain
cn
sampl
microbiolog
evalu
includ
specif
real
time
pcr
cryptococcu
spp
perform
sampl
lung
cn
bone
marrow
spleen
liver
uteru
pcr
cycl
wwwnaturecomscientificreport
wwwnaturecomscientificreport
threshold
valu
consid
neg
plasma
csf
sampl
test
real
time
pcr
cryptococcu
antigen
crag
later
flow
assay
lfa
immi
inc
norman
oklahoma
discrimin
c
neoforman
var
grubii
c
neoforman
var
neoforman
c
gattii
achiev
amplif
rrna
intergen
spacer
ig
region
follow
forward
revers
sanger
sequenc
amplicon
ident
cryptococc
speci
assign
base
match
ig
sequenc
cryptococcu
refer
strain
c
gattii
cb
atcc
cb
atcc
c
neoforman
var
grubii
atcc
atcc
c
neoforman
var
neoforman
atcc
describ
previous
cryptococc
strain
isol
cultur
autopsi
sampl
underw
consensu
multilocu
sequenc
type
scheme
c
neoforman
c
gattii
addit
serom
type
strain
determin
multiplex
pcr
describ
previous
antifungogram
perform
strain
use
sensititr
yeaston
suscept
plate
trek
diagnost
system
thermo
fisher
scientif
oakwood
villag
usa
statist
method
descript
analysi
perform
use
univari
statist
mean
standard
deviat
continu
variabl
frequenc
distribut
categor
variabl
analys
data
manipul
implement
done
use
stata
mp
version
stata
colleg
station
tx
usa
tabl
median
age
year
rang
year
case
men
hivinfect
patient
posit
hiv
test
result
report
clinic
record
appar
unknown
clinician
case
four
hivinfect
patient
art
durat
art
report
one
case
headach
common
symptom
patient
follow
fever
vomit
eight
case
upon
admiss
hospit
eight
patient
confus
andor
agit
two
patient
letharg
anoth
two
fulli
comatos
mening
sign
detect
seven
patient
mean
time
admiss
death
day
ci
cryptococc
infect
consid
first
clinic
diagnost
option
confirm
case
wherea
includ
differenti
diagnosi
eight
patient
antifung
treatment
fluconazol
amphotericin
b
prescrib
seven
patient
five
clinic
suspect
case
seven
patient
die
within
hour
admiss
hivposit
patient
die
within
one
week
admiss
clinic
record
remain
case
includ
studi
review
clinic
diagnosi
cryptococc
infect
among
three
hivinfect
patient
clinic
diagnos
cryptococc
mening
evid
cryptococc
infect
found
autopsi
caus
death
identifi
toxoplasmosi
two
case
tuberculosi
one
case
tabl
show
final
caus
death
cryptococc
speci
associ
diagnos
identifi
cda
well
result
pa
stain
cryptococcu
real
time
pcr
crag
test
differ
sampl
analys
identif
cryptococc
speci
success
case
two
case
tissu
sampl
provid
insuffici
dna
perform
ig
amplif
sequenc
interestingli
among
case
identifi
five
c
gattii
wherea
remain
case
c
neoforman
var
grubii
twelv
case
diagnos
dissemin
infect
remain
meningoencephalitisth
cn
affect
case
follow
affect
organ
pa
pcr
posit
lung
spleen
liver
bone
marrow
kidney
addit
five
six
deceas
women
pathogen
detect
uteru
sampl
one
case
detect
placenta
cryptococcu
found
differ
sampl
patient
case
organ
affect
c
neoforman
var
grubii
c
gattii
infect
mean
vs
organ
posit
pa
stain
specif
histopatholog
differ
observ
two
cryptococcu
speci
molecular
test
expand
detect
cryptococcu
addit
tissu
neg
pa
stain
contrast
two
tissu
sampl
posit
pa
stain
neg
real
time
pcr
period
acidschiff
stain
grocottgomorimethenamin
silver
stain
show
ident
result
repres
histopatholog
imag
differ
affect
tissu
shown
fig
cryptococcu
strain
character
eight
strain
isol
cultur
seven
csf
one
blood
molecular
character
antifung
suscept
cryptococc
strain
isol
shown
tabl
c
neoforman
var
grubii
correspond
vni
molecular
type
wherea
two
differ
genotyp
vgi
vgiv
identifi
two
c
gattii
isol
serom
type
found
c
neoforman
isol
strain
found
among
c
gattii
strain
minimum
inhibitori
concentr
mic
varieti
antifung
agent
determin
tabl
triazol
antifung
agent
fluconazol
voriconazol
itraconazol
posaconazol
mic
less
equal
defin
epidemiolog
cutoff
valu
ecv
one
isol
show
mic
flucytosin
one
dilut
higher
ecv
although
isol
present
mic
amphotericin
mic
three
c
neoforman
molecular
type
vni
two
c
gattii
one
dilut
higher
defin
ecv
larg
seri
nearli
autopsi
perform
thorough
histopatholog
microbiolog
analysi
fatal
cryptococc
infect
mozambiqu
five
brazil
sever
studi
cryptococc
infect
carri
brazil
data
mozambiqu
inde
despit
highli
endem
area
hiv
literatur
search
unabl
find
report
describ
burden
pathogen
countri
thu
knowledg
largest
autopsybas
descript
fatal
cryptococc
infect
mozambiqu
interestingli
albeit
maputo
manau
two
site
differ
countri
term
climat
incom
result
obtain
similar
hiv
preval
deceas
wwwnaturecomscientificreport
wwwnaturecomscientificreport
patient
cryptococcu
associ
mortal
hiv
posit
patient
studi
cryptococcu
respons
death
among
hivinfect
patient
figur
agreement
current
estim
aidsrel
death
due
cm
although
treatment
art
led
import
reduct
mortal
hivinfect
patient
subsaharan
africa
present
cryptococcalrel
death
seem
remain
similar
estim
agreement
autopsi
seri
hivassoci
cryptococcosi
frequent
present
dissemin
infect
studi
report
one
half
cryptococc
wwwnaturecomscientificreport
wwwnaturecomscientificreport
infect
detect
hivinfect
patient
receiv
art
seri
quarter
hivposit
case
art
unfortun
durat
art
avail
one
case
case
histori
art
high
viral
load
therefor
like
repres
treatment
failur
default
explan
cryptococc
infect
patient
receiv
adequ
art
includ
recent
treatment
initi
patient
low
count
late
hiv
diagnosi
case
immun
reconstitut
inflammatori
syndrom
might
also
present
seri
despit
progress
art
deploy
subsaharan
africa
close
hivinfect
patient
continu
present
health
facil
advanc
hiv
diseas
therebi
high
risk
cryptococc
infect
death
regard
crag
detect
three
week
onset
cm
symptom
therefor
screen
asymptomat
hiv
patient
follow
preemptiv
antifung
treatment
might
identifi
patient
risk
develop
diseas
contribut
reduc
cmrelat
mortal
present
studi
case
die
within
first
week
hospit
admiss
contrast
seri
report
mean
two
week
admiss
death
sever
factor
might
contribut
rapid
fatal
outcom
seri
firstli
low
frequenc
clinic
suspicion
cryptococcosi
may
explain
absenc
prescrib
antifung
treatment
half
patient
hand
patient
may
present
hospit
advanc
sever
stage
cryptococc
infect
consid
seven
die
within
three
day
admiss
four
within
hour
longest
hospit
admiss
involv
child
die
c
gattii
mening
two
month
hospit
admiss
c
gattii
infect
rare
children
child
seri
infect
often
occur
previous
healthi
children
present
cn
involv
littl
knowledg
avail
c
gattii
subsaharan
africa
obtain
studi
perform
south
africa
interestingli
studi
four
cryptococc
infect
mozambiqu
due
c
gattii
infect
although
number
small
interpret
caution
data
contrast
previou
find
south
africa
c
gattii
repres
cryptococc
strain
isol
twoyear
period
c
gattii
infect
mainli
report
immunocompet
host
studi
south
africa
reveal
affect
immunocompromis
patient
well
report
vgi
c
gattii
molecular
type
much
like
affect
immunocompet
patient
vgiv
howev
genotyp
detect
hivinfect
patient
studi
strain
c
neoforman
var
grubii
molecular
type
vni
possess
serom
type
similar
strain
describ
south
africa
knowledg
first
report
c
gattii
mozambiqu
type
detect
previous
report
south
africa
although
clinic
breakpoint
avail
cryptococcu
antifung
suscept
test
suggest
clear
resist
pattern
mic
one
dilut
ecv
found
isol
autopsi
report
fatal
c
gattii
infect
immunocompet
patient
report
may
explain
fact
distinct
c
gattii
c
neoforman
perform
mani
studi
although
number
small
dissemin
infect
seem
less
intens
hivinfect
patient
c
gattii
compar
c
neoforman
larger
studi
need
better
assess
histopatholog
featur
c
gattii
hivinfect
patient
moreov
studi
base
postmortem
examin
perform
better
assess
mortal
attribut
specif
pathogen
lowand
middleincom
countri
accur
mortal
data
impact
public
health
polici
exampl
guid
prophylact
treatment
scheme
infecti
diseas
conclus
studi
highlight
substanti
mortal
associ
cryptococc
infect
among
hivinfect
patient
support
current
recommend
crag
screen
preemptiv
therapi
even
relev
set
insuffici
premortem
clinic
suspicion
given
highli
preval
lifethreaten
opportunist
infect
ethic
approv
consent
particip
studi
protocol
receiv
approv
nation
mozambican
ethic
committe
ethic
committe
hospit
clinic
barcelona
spain
approv
file
mia
cda
procedur
conduct
verbal
inform
consent
provid
rel
relev
data
within
paper
addit
data
use
transfer
monitor
isglob
data
manag
biostatist
unit
contact
email
ubioesdm
isglobalorg
